Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A-Reference-Cited by-同舟云学术

Tailoring hemostatic therapies to lower inhibitor development in previously untreated patients with severe hemophilia A

Published:2016-06-22 Issue:7 Volume:14 Page:1330-1336
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Mannucci P. M.¹,Mancuso M. E.¹,Franchini M.²

Affiliation:

1. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center; Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico and University of Milan; Milan Italy

2. Department of Transfusion Medicine and Hematology; Carlo Poma Hospital; Mantova Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13356/fullpdf

Reference56 articles.

1. Hemophilia A in the third millennium;Franchini;Blood Rev,2013

2. Aging among persons with hemophilia: contemporary concerns;Angelini;Semin Hematol,2016

3. The past and future of haemophilia: diagnosis, treatments, and its complications;Peyvandi;Lancet,2016

4. Advances in the clinical management of inhibitors in hemophilia A and B;Leissinger;Semin Hematol,2016

5. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group;Gringeri;Blood,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973);Journal of Clinical Medicine;2022-06-15

2. An update of the current pharmacotherapeutic armamentarium for hemophilia A;Expert Opinion on Pharmacotherapy;2021-08-18

3. Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up;British Journal of Haematology;2021-02-03

4. ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers;Seminars in Thrombosis and Hemostasis;2021-02

5. Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa;Farmeconomia. Health economics and therapeutic pathways;2020-04-03